Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Oct 8, 2025, 8:00 PM EDT
Affymax Revenue
Affymax had revenue of $42.00K in the quarter ending June 30, 2014, a decrease of -92.00%. This brings the company's revenue in the last twelve months to $42.00K, down -99.86% year-over-year. In the year 2013, Affymax had annual revenue of $1.37M, down -98.55%.
Revenue (ttm)
42.00K
Revenue Growth
-99.86%
P/S Ratio
1.77
Revenue / Employee
21.00K
Employees
4
Market Cap
74.49K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2013 | 1.37M | -93.00M | -98.55% |
Dec 31, 2012 | 94.37M | 46.65M | 97.76% |
Dec 31, 2011 | 47.72M | -64.80M | -57.59% |
Dec 31, 2010 | 112.52M | -2.38M | -2.07% |
Dec 31, 2009 | 114.90M | 32.05M | 38.68% |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
AMJ Global Technology | 39.00 |